Saturday 17 October 2026
Export AWIN’s income statement to Excel — free account
AERWINS Technologies Inc.
AWIN Technology Scientific & Technical Instruments
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow AWIN
| Older periods | Jun '23 | Sep '23 | Dec '23 | Mar '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | — | — |
P/S ratio |
13.13 | 9.33 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(4.85) | 39.02 | — | — | |
P/B ratio |
0.00 | 0.00 | — | — | |
Price to Tangible BV |
0.00 | 0.00 | — | — | |
EV/Sales |
15.04 | 11.89 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(1.71) | (1.45) | — | — | |
EV/FCF |
(1.70) | (1.44) | — | — | |
Quick Ratio |
0.09 | 0.08 | 0.00 | 0.03 | |
Current Ratio |
0.47 | 0.24 | 0.08 | 0.19 | |
Net Debt/EBITDA |
(0.38) | (1.24) | 0.19 | (6.30) | |
Debt/Assets |
53.02% | 130.28% | 142.44% | 211.30% | |
Debt/Equity |
(0.31) | (0.26) | (0.08) | (0.26) | |
Asset Turnover |
0.03 | 0.03 | 0.00 | 0.00 | |
Operating CF/Net income |
0.43 | (0.09) | (0.43) | (0.04) | |
Capex/Depreciation |
(0.27) | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
— | (4.78) | (14.26) | (6.28) | |
Research and Development Expense of Revenue |
18,489.49% | (125.75%) | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16,504.67% | 4,768.56% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1,245.14% | 4,153.12% | 0.00% | 0.00% | |
Graham Net Nets |
(0.53) | (1.06) | — | — | |
Graham Number |
150.73 | 160.24 | — | — | |
Earnings Yield |
(120.23%) | (208.31%) | — | — | |
Free Cash Flow Yield |
(67.52%) | (88.49%) | — | — | |
Revenue per Share |
0.05 | 0.06 | 0.00 | 0.00 | |
Operating CF per Share |
(8.66) | 0.59 | 2.06 | (0.52) | |
Capex per Share |
(0.10) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(8.76) | 0.59 | 2.06 | (0.52) | |
Cash per Share |
0.06 | 0.04 | 0.00 | 0.22 | |
Shareholders Equity per Share |
(20.00) | (23.92) | (31.42) | (10.81) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(20.00) | (23.92) | (31.42) | (10.81) | |
Free Cash Flow |
(4.98) | 0.37 | 1.21 | (0.38) | |
Working Capital |
(6.08) | (8.86) | (11.97) | (4.31) | |
Capital Expenditures |
(0.06) | 0.00 | — | — | |
Net Current Asset Value |
(12.55) | (15.19) | (18.48) | (7.97) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
2.22 | 0.00 | — | — | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
3.45 | 3.55 | 2.80 | 3.59 | |
Average Assets |
61.80 | 60.87 | 6.42 | 6.17 | |
Average Common Equity |
(7.82) | (9.94) | (8.29) | (6.09) |
Columns are period end dates